January 2026 in “International Journal of Dermatology Venereology and Leprosy Sciences” This study suggests that metformin's ability to enhance insulin sensitivity may improve acanthosis nigricans by addressing the underlying insulin resistance.
January 2026 in “International Journal of Medical and All Body Health Research” This study found that both intralesional corticosteroids (TAC) and platelet-rich plasma (PRP) are effective for treating patchy alopecia areata, with TAC providing faster early results but PRP offering better long-term safety and lower relapse rates.
December 2025 in “IP Indian Journal of Clinical and Experimental Dermatology” This study observed that topical dinitrochlorobenzene was significantly more effective than topical betamethasone in treating patients with alopecia areata, with 53.3% achieving excellent hair regrowth compared to 13.3% using betamethasone.
December 2025 in “Cureus” In this case report, a unique immunological mechanism was observed in an 11-year-old girl where the presence of one autoimmune disease appeared to prevent the manifestation of another, leading to the withdrawal of one type of lesion when another appeared.
July 2025 in “The Egyptian Journal of Hospital Medicine” This study found that intralesional methotrexate and triamcinolone acetonide have similar efficacy for localized alopecia areata in adults, but differ in safety profiles, with methotrexate associated with hyperpigmentation and triamcinolone with atrophy.
September 2024 in “Electronic Journal of General Medicine” This case report describes a healthy Thai male who developed severe folliculitis following diode laser hair removal, which improved significantly with prednisolone and benzoyl peroxide treatment.
In this case report, researchers observed that a malnourished male patient developed pseudoglucagonoma syndrome, characterized by necrolytic migratory erythema and diffuse hair loss, following Frey's surgery, which rapidly improved with enhanced nutrition.
March 2024 in “Indian Journal of Dermatology” In this case report, a 42-year-old male diagnosed with Cronkhite-Canada syndrome presented symptoms like chronic diarrhea, significant weight loss, skin hyperpigmentation, alopecia, and nail dystrophy, with endoscopic findings revealing numerous gastrointestinal polyps.
January 2024 in “Brazilian journal of veterinary pathology” In this case report, a 6-year-old spayed female Samoyed dog presented with non-pruritic alopecia and hyperpigmentation on the hips and back, with unremarkable bloodwork and negative Cushing's disease and skin tests.
November 2023 in “Journal of the American Academy of Dermatology” This study explored spontaneous repigmentation after phenol-croton oil peels in skin of color, finding that temporary hypopigmentation resolved by day 21 in both a black-skin domestic pig model and human clinical observations, highlighting potential for these procedures despite past concerns about pigmentation issues.
June 2023 in “British journal of dermatology/British journal of dermatology, Supplement” This case report describes a 15-year-old girl with features of Becker naevus syndrome, highlighting the importance of DNA analysis from skin to confirm the diagnosis after 9 years of symptoms.
June 2023 in “British Journal of Dermatology” In this case series, researchers observed a rare presentation of lichen planopilaris confined to the face in six patients, with dermoscopic and histopathological profiles indicating scarring alopecia and pigment changes, and suggested that shaving and mustard oil use might trigger the condition.
This report describes a case of Goltz syndrome in a 12-year-old Saudi girl, highlighting the variability in symptoms and the importance of documenting such rare syndromes.
April 2023 in “The Egyptian Journal of Hospital Medicine” The study found that intralesional injection of platelet-rich plasma appears safe and may be effective for treating post-burn scars, with shorter scar durations showing better results.
January 2023 in “Dermatologic therapy” This study reports that diphenylcyclopropenone topical immunotherapy resulted in any hair regrowth for 69% of patients with alopecia areata, but with common side effects including mild to severe contact dermatitis.
September 2022 in “Frontiers in Medicine” New treatments and drugs show promise for improving skin pigmentation and regeneration.
August 2022 in “Frontiers in genetics” This study identified a novel bi-allelic missense variant in the DSC3 gene linked to severe Hypotrichosis with Recurrent Skin Vesicles in a Saudi child, supporting its role in the condition.
November 2021 in “CRC Press eBooks” This review discusses the genetic and metabolic factors influencing hair pigmentation, as well as conditions leading to hypo- or depigmented hair, and reports no new experimental findings.
April 2021 in “Authorea (Authorea)” In this case report, a woman with segmental vitiligo and hemifacial atrophy showed signs of stabilization after treatment with chloroquine and betamethasone pulse, suggesting a common underlying cause for these dermatoses.
September 2020 in “Journal of Mind and Medical Sciences” This study reported that using a Cutera Xeo laser with specific probes may help treat rosacea symptoms like diffuse facial erythema and telangiectasias, with some risks like bruises and hypopigmentation.
This study aims to describe the trichoscopic pattern of chemotherapy-induced alopecia and its changes during different phases of chemotherapy.
April 2019 in “Journal of Investigative Dermatology” This study found that post-hematopoietic cell transplantation epidermal grafting significantly reduced chronic wound size in patients with recessive dystrophic epidermolysis bullosa.
This study found that transgenic expression of Endothelin 3 in mice can maintain a dark pigmentation phenotype independently of Mc1r signaling by regulating melanogenic genes.
January 2017 in “Dermatology Review” This article discusses skin lesions in chronic graft-versus-host disease and highlights the importance of coordinated care between haematologists and dermatologists for effective management; it presents no new clinical results.
April 2016 in “Journal of the American Academy of Dermatology” Incorrect injection of corticosteroids for alopecia areata can cause skin problems.
May 2015 in “Actas Dermo-Sifiliográficas” A young man was unexpectedly diagnosed with basal cell carcinoma after a scalp examination and confocal microscopy.
May 2015 in “Journal of the American Academy of Dermatology” New hair after alopecia areata can be thinner and change color but usually keeps the same shape.
This study identified 92 novel regulators of melanogenesis, highlighting Aldehyde dehydrogenase 1A1 as a potential target for developing new treatments for hyperpigmentation disorders like melasma.
This study identified ALDH1A1 as a regulator of melanogenesis and suggests its inhibition, through agents like cyanamide, may be a promising therapeutic approach for treating hyperpigmentation disorders such as melasma.
September 2013 in “International journal of radiation oncology, biology, physics” This study found that high dose rate electronic brachytherapy was effective for non-melanoma skin cancer, with no recurrences and good to excellent cosmesis up to three years post-treatment.